The Chemistry of Addiction: Pharmacology & Mechanisms

By the end of this module, you will be able to:

• Explain the functions of key neurotransmitters involved in addiction
• Differentiate between agonists, antagonists, and partial agonists
• Describe the mechanisms of action for major drug classes
• Understand pharmacokinetic principles relevant to addiction
• Apply pharmacological knowledge to clinical scenarios

Dopamine: The Motivation Molecule

Function: Reward, motivation, motor control, attention

Key Pathways:

• Mesolimbic: VTA → Nucleus Accumbens (reward, motivation)
• Mesocortical: VTA → Prefrontal Cortex (cognition, executive function)
• Nigrostriatal: Substantia Nigra → Striatum (motor control)
• Tuberoinfundibular: Hypothalamus → Pituitary (hormone regulation)

Role in Addiction:

• Primary mediator of drug reward
• Signals salience ("this is important, pay attention")
• Drives motivation to seek substances
• Depletion contributes to anhedonia in withdrawal

Clinical Note: Dopamine is not simply "the pleasure chemical"—it more accurately signals motivational salience, driving us toward rewards both natural and drug-induced.

Serotonin (5-HT): The Mood Regulator

Function: Mood, sleep, appetite, impulse control, cognition

Role in Addiction:

• Modulates impulsivity and decision-making
• MDMA/ecstasy causes massive serotonin release
• Alcohol affects serotonin transmission
• SSRIs sometimes used in addiction treatment (for comorbid depression)

Key Point: Low serotonin function is associated with impulsivity and aggression, which increase addiction risk.

GABA: The Brain's Brake

Function: Primary inhibitory neurotransmitter; reduces neuronal excitability

Role in Addiction:

• Alcohol, benzodiazepines, barbiturates enhance GABA
• Produces sedation, anxiolysis, muscle relaxation
• GABA-enhancing drugs are highly addictive due to anti-anxiety effects
• Sudden cessation after chronic use → hyperexcitability (seizures)

Clinical Pearl: GABA-ergic drug withdrawal (alcohol, benzodiazepines) can be life-threatening due to seizure risk. Always assess and medically manage.

Glutamate: The Accelerator

Function: Primary excitatory neurotransmitter; involved in learning, memory

Role in Addiction:

• Drug-associated learning depends on glutamate
• Alcohol inhibits glutamate (contributing to intoxication)
• Glutamate rebound contributes to withdrawal symptoms
• Emerging treatments target glutamate (e.g., N-acetylcysteine)

Endorphins: Natural Painkillers

Function: Pain modulation, stress response, reward

Role in Addiction:

• Opioid drugs mimic endorphins
• Activate mu-opioid receptors
• Produce analgesia and euphoria
• Exercise releases endorphins (natural reward)

Norepinephrine: The Stress Signal

Function: Alertness, arousal, stress response ("fight or flight")

Role in Addiction:

• Stimulants increase norepinephrine
• Elevated in opioid withdrawal (contributes to anxiety, restlessness)
• Targeted by some withdrawal medications (e.g., clonidine)

Acetylcholine: The Nicotine Target

Function: Learning, memory, muscle activation, attention

Role in Addiction:

• Nicotine binds to nicotinic acetylcholine receptors
• Modulates dopamine release
• Important for cognitive effects of nicotine

Key Concepts

Receptor: Protein that binds specific molecules (ligands) and triggers cellular response

Ligand: Any molecule that binds to a receptor

• Endogenous: Naturally produced (dopamine, endorphins)
• Exogenous: From outside (drugs, medications)

Affinity: How strongly a ligand binds to a receptor

Efficacy: How much biological response a ligand produces once bound

Agonists, Antagonists, and Partial Agonists

| Type | Definition | Example | Clinical Use | |------|------------|---------|--------------| | Full Agonist | Binds receptor, produces maximum response | Heroin, Morphine, Fentanyl | Pain relief (but high abuse potential) | | Partial Agonist | Binds receptor, produces submaximal response | Buprenorphine | MAT for opioid use disorder | | Antagonist | Binds receptor, blocks response | Naloxone, Naltrexone | Overdose reversal, relapse prevention | | Inverse Agonist | Binds receptor, produces opposite response | Some GABA compounds | Research applications |

The Ceiling Effect

Partial agonists have a "ceiling" beyond which increased dose does not increase effect:

Buprenorphine Example:

• At low doses: Produces opioid effects (prevents withdrawal)
• At high doses: Effects plateau (ceiling)
• Result: Lower overdose risk than full agonists
• Clinical advantage: Safer for outpatient treatment

Key Parameters

Absorption: How drug enters bloodstream

• Route matters: IV > smoking > intranasal > oral
• Faster absorption = more intense high = more addictive

Distribution: How drug spreads through body

• Lipophilic drugs (fat-soluble) cross blood-brain barrier easily
• This is why heroin hits faster than morphine (more lipophilic)

Metabolism: How body breaks down drug

• Primarily in liver via cytochrome P450 enzymes
• Genetic variations affect metabolism speed
• Drug interactions can inhibit/induce metabolism

Elimination: How drug leaves body

• Half-life: Time for blood concentration to reduce by half
• Longer half-life = less frequent dosing, milder withdrawal

Clinical Implications

| Drug | Route | Half-life | Withdrawal Onset | |------|-------|-----------|------------------| | Heroin | IV/Smoked | 30 min | 6-12 hours | | Fentanyl | IV/Smoked | 3-4 hours | 4-6 hours | | Oxycodone | Oral | 3-4 hours | 8-12 hours | | Methadone | Oral | 24-36 hours | 24-48 hours | | Buprenorphine | Sublingual | 24-42 hours | 24-72 hours |

Clinical Pearl: Longer-acting medications like methadone and buprenorphine produce more stable blood levels, reducing cycles of intoxication and withdrawal.

Opioids

Receptors: Mu (μ), Kappa (κ), Delta (δ)

Mechanism:

1. Bind to mu-opioid receptors (primarily)
2. Activate inhibitory G-proteins
3. Reduce neuron firing
4. In VTA: Disinhibit dopamine neurons → increased dopamine in NAc
5. Produce analgesia, euphoria, respiratory depression

Tolerance Mechanism:

• Receptor internalization (fewer surface receptors)
• Uncoupling of receptors from G-proteins
• Downstream adaptations

Withdrawal Mechanism:

• Loss of inhibitory input → neuronal hyperactivity
• Norepinephrine surge → anxiety, piloerection, sweating
• GI effects from loss of opioid-induced slowing

Stimulants

Cocaine Mechanism:

1. Blocks dopamine transporter (DAT)
2. Prevents reuptake of dopamine from synapse
3. Dopamine accumulates → intense euphoria
4. Also blocks norepinephrine and serotonin transporters
5. Short-acting → rapid crash

Methamphetamine Mechanism:

1. Also blocks DAT
2. PLUS: Reverses transporter direction
3. Dumps stored dopamine into synapse
4. Enters neurons and releases vesicular dopamine
5. Much longer-lasting than cocaine
6. More neurotoxic

Amphetamine (Adderall) Mechanism:

• Similar to methamphetamine but less potent
• Prescribed for ADHD (paradoxically calming in ADHD brains)
• Lower doses, oral route → less abuse potential than street meth
• Still carries addiction risk, especially in non-ADHD users

Alcohol

Multiple Mechanisms:

| System | Effect | Result | |--------|--------|--------| | GABA-A | Enhanced | Sedation, anxiolysis | | NMDA Glutamate | Inhibited | Impaired memory, coordination | | Dopamine | Increased (indirect) | Reward, reinforcement | | Serotonin | Modulated | Mood effects | | Opioid | Endorphin release | Euphoria |

Withdrawal Danger:

• Chronic alcohol suppresses brain activity via GABA/glutamate
• Brain compensates by upregulating excitatory systems
• Sudden cessation → hyperexcitability
• Can cause seizures, delirium tremens (DTs), death

Benzodiazepines

Mechanism:

1. Bind to GABA-A receptor at specific benzodiazepine site
2. Enhance GABA binding (allosteric modulation)
3. Increase frequency of chloride channel opening
4. Result: Enhanced inhibition → sedation, anxiolysis, anticonvulsant

Cross-Tolerance with Alcohol:

• Both enhance GABA transmission
• Can substitute for each other
• Benzodiazepines used for alcohol withdrawal

Danger of Combination:

• Alcohol + benzodiazepines = synergistic CNS depression
• Leading cause of polydrug overdose death

Nicotine

Mechanism:

1. Binds to nicotinic acetylcholine receptors (nAChRs)
2. Located on dopamine neurons in VTA
3. Stimulates dopamine release
4. Also affects glutamate, GABA, endorphins
5. Produces alertness, stress relief, appetite suppression

Rapid Tolerance:

• Receptors desensitize within minutes of exposure
• Leads to frequent dosing (every 1-2 hours for smokers)
• Overnight abstinence → resensitization → morning craving

Cannabis

Mechanism:

1. THC binds to CB1 cannabinoid receptors
2. Located throughout brain (cortex, hippocampus, basal ganglia, cerebellum)
3. Mimics endogenous cannabinoids (anandamide, 2-AG)
4. Modulates release of other neurotransmitters
5. Produces relaxation, euphoria, altered perception, appetite stimulation

Endocannabinoid System:

• Naturally regulates stress, pain, appetite, memory
• "Retrograde signaling" — released by postsynaptic neuron, acts on presynaptic
• CB1: Brain (psychoactive effects)
• CB2: Immune system, periphery

Dangerous Combinations

| Combination | Mechanism | Risk | |-------------|-----------|------| | Opioids + Benzodiazepines | Synergistic CNS depression | Respiratory arrest | | Opioids + Alcohol | Same | Respiratory arrest | | Cocaine + Alcohol | Forms cocaethylene | Cardiotoxicity | | Stimulants + MAOIs | Tyramine reaction | Hypertensive crisis | | MDMA + SSRIs | Serotonin excess | Serotonin syndrome |

Medication Considerations

When prescribing for patients with addiction history:

• Check prescription drug monitoring programs (PDMPs)
• Consider abuse potential of medications
• Be aware of interactions with substances of abuse
• Non-controlled alternatives when appropriate

• Dopamine signals motivational salience; GABA inhibits, glutamate excites
• Agonists activate receptors; antagonists block them; partial agonists have a ceiling
• Pharmacokinetics (absorption, distribution, metabolism, elimination) determine drug effects
• Each drug class has specific mechanisms targeting different neurotransmitter systems
• Drug combinations can produce synergistic, life-threatening effects
• Understanding pharmacology informs safe prescribing and overdose management

---

Next Module: Risk Factors: Genetics, Epigenetics & Adverse Childhood Experiences →